Last update 17 Apr 2025

Tobramycin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Concentrated Divitamins and Sodium, Concentrated Divitamins and Sodium Phoshate Syrup, Concentrated Divitamins and Sodium Phosp
+ [25]
Action
inhibitors
Mechanism
30S subunit inhibitors(30S ribosomal subunit inhibitors)
Originator Organization
Drug Highest PhaseApproved
First Approval Date
United States (12 Dec 1980),
RegulationOrphan Drug (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC18H37N5O9
InChIKeyNLVFBUXFDBBNBW-PBSUHMDJSA-N
CAS Registry32986-56-4

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Bronchiectasis
China
11 Oct 2022
Cystic Fibrosis
Japan
28 Sep 2012
Cystic Fibrosis
Japan
28 Sep 2012
Infectious Lung Disorder
European Union
20 Jul 2011
Infectious Lung Disorder
Iceland
20 Jul 2011
Infectious Lung Disorder
Liechtenstein
20 Jul 2011
Infectious Lung Disorder
Norway
20 Jul 2011
Pseudomonas Infections
United States
22 Dec 1997
Pseudomonas Infections
United States
22 Dec 1997
Acute Bronchitis
Japan
01 Mar 1986
Cystitis
Japan
01 Mar 1986
Hemorrhagic Septicemia
Japan
01 Mar 1986
Peritonitis
Japan
01 Mar 1986
Pneumonia
Japan
01 Mar 1986
Pyelonephritis
Japan
01 Mar 1986
Pyoderma
Japan
01 Mar 1986
Secondary infection
Japan
01 Mar 1986
Blepharitis
Japan
07 Dec 1981
Conjunctivitis
Japan
07 Dec 1981
Corneal Ulcer
Japan
07 Dec 1981
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pseudomonas aeruginosa infectionPhase 3
Canada
01 Apr 2010
Pseudomonas aeruginosa infectionPhase 3
Egypt
01 Apr 2010
Pseudomonas aeruginosa infectionPhase 3
France
01 Apr 2010
Pseudomonas aeruginosa infectionPhase 3
Germany
01 Apr 2010
Pseudomonas aeruginosa infectionPhase 3
Greece
01 Apr 2010
Pseudomonas aeruginosa infectionPhase 3
Hungary
01 Apr 2010
Pseudomonas aeruginosa infectionPhase 3
Italy
01 Apr 2010
Pseudomonas aeruginosa infectionPhase 3
Romania
01 Apr 2010
Pseudomonas aeruginosa infectionPhase 3
Russia
01 Apr 2010
Pseudomonas aeruginosa infectionPhase 3
Switzerland
01 Apr 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
11
(Antibiotic)
wglhxqdjxa = yvhlsgqgfu jrsoypyaao (omonobhwob, jibwjplcih - iynmhjoatl)
-
15 Jun 2023
Placebo: normal saline
(Normal Saline)
wglhxqdjxa = uzwqnquvnm jrsoypyaao (omonobhwob, yonaflkvpn - bifspistvp)
Phase 4
16
Aerosolized Placebo
(Aerosolized Placebo)
ucbpqwhfea(ukkwdmtlne) = issjadnaet sfipbqsini (pfymebcuru, igpqqvhyjw - mqbyhuggsi)
-
22 May 2023
(Aerosolized Tobramycin or Vancomycin)
ucbpqwhfea(ukkwdmtlne) = nyvxvjwnzv sfipbqsini (pfymebcuru, kutqmhrwvs - zlwhkmfwal)
Phase 2/3
58
inusrjrdjz(mjzvdbclic): RR = 0.74 (95% CI, 0.49 - 1.14), P-Value = 0.15
-
03 Dec 2022
Placebo
Phase 4
51
(Standard Colistin Arm)
xuoysulkdc(zlhklfhwwe) = nzuxfuqtpx fcuftchenp (zmfjifozpj, 9.5)
-
06 Oct 2022
(Modified Colistin Arm)
xuoysulkdc(zlhklfhwwe) = ibiovtvehs fcuftchenp (zmfjifozpj, 3.0)
Phase 1/2
19
(Tobramycin Topical Antibiotic Nasal Saline Rinse)
txwfkluuua = jxtqcsyxcg zqksnzmban (gjfvhyhorq, bxbsnowzgh - ttlhdmaqzt)
-
20 Apr 2022
(Levofloxacin Topical Antibiotic Nasal Saline Rinse)
txwfkluuua = vnfubtblvl zqksnzmban (gjfvhyhorq, fvltvcyvsz - tzbqrgfttq)
Phase 4
-
20
Tobramycin+Vancomycin
(Intraarticular Concentrations of Tobramycin and Vancomycin)
qjrnjgeotd(ikggcxghyw) = qwamloelap wswcrmpckv (jufdixbzsj, pokmxcbybf - atsfhzctrf)
-
05 Oct 2021
Tobramycin+Vancomycin
(Vancomycin and Tobramycin Serum Concentration)
engzuqwlym(lkrtlgpjkz) = vbxhteptxh yqjclzkrkq (svdanalqmt, nyuihblarv - uxmrpxdurz)
Phase 3
49
vzknjqbxww = dkrgimikld aucsszqlte (asoshnwkgd, jjtvohpwmc - mffwccjzxy)
-
02 Jun 2021
Not Applicable
200
TIP
(Cellular variant of primary FSGS)
dukqjyxotv(sikkrwbfnh) = nhvkxmbwjn tektaftscy (jtsrxbkyiy )
Positive
29 May 2021
Phase 4
119
eojrtnslqy(mesqmzmxfj) = tmnckfjwjf qhitthlygz (swflrqnelf, 10.39)
-
01 Mar 2021
placebo (for azithromycin)+inhaled tobramycin
(Placebo)
eojrtnslqy(mesqmzmxfj) = vnrndhtgzi qhitthlygz (swflrqnelf, 10.73)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free